Company intelligence / Profile preview

Egan-Jones Proxy Services

Haverford, Pennsylvania, United States

Ownership: Private
Development stage: Other

Overview

Egan-Jones Proxy Services is a leading, independent, employee-owned provider of proxy guidance and voting services, established in 2002[1][3][5]. The company supports institutional, retail, and governmental investors in exercising their shareholder rights by offering policy-driven, automated proxy voting solutions, N-PX reporting, and customized governance recommendations. It is distinct from ISS and Glass Lewis in that it does not provide corporate consulting services, aiming to minimize conflicts of interest[5]. Egan-Jones is not a biotechnology, pharmaceutical, or healthcare product company and does not have a drug pipeline[1][3][5].

Industry: Consulting

Beyond the preview

Go deeper on Egan-Jones Proxy Services.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Egan-Jones Proxy Services.

Explore the full profile